Skip to main content
. Author manuscript; available in PMC: 2019 Dec 5.
Published in final edited form as: Leukemia. 2019 Jun 17;33(8):1835–1850. doi: 10.1038/s41375-019-0512-y

Table 2.

Variant annotation aids the interpretation of clinical relevance

Variant
number
Amino acid change Chrom Position,
hg19
HGNC
symbol
Effect Ensembl
transcript ID
COSMIC
count,
Version
86
COSMIC
Cancer
Gene
Census
gnomAD
%
1KG
ALT
Freq
%
UK10K
ALT
Freq
%
ExAC
ALT %
1* p.P72R/c.215C>G 17 7579472 TP53 missense ENST00000269305 162 TRUE 66 54 75 66
2 p. V73G/C.218T>G 17 7579469 TP53 missense ENST00000269305 TRUE
3 p.G117R/c.349G>A 17 7579338 TP53 missense ENST00000269305 TRUE
4 p.S185N/c.554G>A 17 7578376 TP53 missense ENST00000269305 1 TRUE 0.0004 0.001
5 p.N210D/c.628A>G 17 7578221 TP53 missense ENST00000269305 1 TRUE
6 p.R248Q/c.743G>A 17 7577538 TP53 missense ENST00000269305 1085 TRUE 0.002 0.005
7 p.R283C/c.847C>T 17 7577091 TP53 missense ENST00000269305 22 TRUE 0.009 0.008
Variant
number
Amino acid change GERP phyloP CADD SIFT Poly
Phen2
Mutation
Taster
FATHMM InterPro ALT allele
Freq %
Clinically
relevant
1* p.P72R/c.215C>G <2 1.355 0.4 T B T D 49 No
2 p.V73G/c.218T>G <2 <1 0.003 T B T D 51 No
3 p.G117R/c.349G>A 4.75 2.63 32 D D D D P53 DNA-binding domain 32 Yes
4 p.S185N/c.554G>A <2 <1 0.4 T B T D P53 DNA-binding domain 40 No
5 p.N210D/c.628A>G <2 <1 9.6 T B T D P53 DNA-binding domain 20 No
6 p.R248Q/c.743G>A 3.65 1.305 34 D D D D P53 DNA-binding domain 48 Yes
7 p.R283C/c.847C>T 4.01 1.278 26 D B D D P53 DNA-biriding domain 27 Yes
*

Note this this variant is listed in COSMIC with a high count, but is also reported at a high frequency in population databases and is a non-pathogenic germline variant

Abbreviations. Population databases: gnomAD, The Genome Aggregation Database, Version r2.0.2; 1KG, The 1000 Genomes Project Phase 3 V5b; UK10K, The UK10K project Version 20160215; ExAC, Exome Aggregation Consortium Version 0.3.1.

Evolutionary conservation scores: GERP, Genomic Evolutionary Rate Profiling for SNVs. The higher the score, the more evolutionarily conserved the position is. Scores ≥2 were considered conserved; phyloP conservation score for SNVs. Scores ≥1 were considered conserved.

In silico prediction tools for SNVs: CADD, A Combined Annotation Dependent Depletion score Version 1.3. The higher the score, the more deleterious the variant. A score of 20 was used as a threshold for deleteriousness; SIFT, Sorting Intolerant from Tolerant. T= tolerated, D=damaging; Polyphen2, Polymorphism Phenotyping v2. B=benign, D=probably damaging; MutationTaster, T=tolerated, D=probably damaging; FATHMM, Functional Analysis through Hidden Markov Models. T=tolerated, D=damaging. The pipeline uses dbNSFP Version 2.6 for SIFT, Polyphen2, MutationTaster and FATHMM.

InterPro: Protein sequence analysis and classification. Provides protein domain information. hg19 version from the UCSC Genome Browser.

Clinically relevant variants were conserved variants with a population frequency ≤0.1%, CADD score ≥20 and predicted to be damaging by 3 of 4 prediction tools.